SEC Filings

SEC Filings

Filing date	Description	Form	View
Nov 09, 2007	Amended Registration statement for face-amount certificate companies	S-1/A	View HTML 0001193125-07-242397.pdf 0001193125-07-242397.rtf 0001193125-07-242397.xls
Nov 08, 2007	Registration of certain classes of securities 12(b) of the Securities Exchange Act	8-A12B	View HTML 0001193125-07-240490.pdf 0001193125-07-240490.rtf 0001193125-07-240490.xls
Nov 07, 2007	Amended Registration statement for face-amount certificate companies	S-1/A	View HTML 0001193125-07-236994.pdf 0001193125-07-236994.rtf 0001193125-07-236994.xls
Nov 07, 2007	FWP	FWP	View HTML 0001193125-07-237554.pdf 0001193125-07-237554.rtf 0001193125-07-237554.xls
Nov 07, 2007	FWP	FWP	View HTML 0001193125-07-238581.pdf 0001193125-07-238581.rtf 0001193125-07-238581.xls
Oct 26, 2007	Amended Registration statement for face-amount certificate companies	S-1/A	View HTML 0001193125-07-227019.pdf 0001193125-07-227019.rtf 0001193125-07-227019.xls
Sep 11, 2007	Amended Registration statement for face-amount certificate companies	S-1/A	View HTML 0001193125-07-199160.pdf 0001193125-07-199160.rtf 0001193125-07-199160.xls
Aug 14, 2007	Amended Registration statement for face-amount certificate companies	S-1/A	View HTML 0001193125-07-182940.pdf 0001193125-07-182940.rtf 0001193125-07-182940.xls
Jul 06, 2007	Amended Registration statement for face-amount certificate companies	S-1/A	View HTML 0001193125-07-151101.pdf 0001193125-07-151101.rtf 0001193125-07-151101.xls
May 25, 2007	Registration statement for face-amount certificate companies	S-1	View HTML 0001193125-07-123332.pdf 0001193125-07-123332.rtf 0001193125-07-123332.xls

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE